BioMaxima S.A. (WSE:BMX)
Poland flag Poland · Delayed Price · Currency is PLN
11.95
+0.30 (2.58%)
Dec 15, 2025, 3:39 PM CET

BioMaxima Revenue

BioMaxima had revenue of 15.91M PLN in the quarter ending September 30, 2025, with 27.67% growth. This brings the company's revenue in the last twelve months to 59.11M, up 17.50% year-over-year. In the year 2024, BioMaxima had annual revenue of 52.85M with 12.96% growth.

Revenue (ttm)
59.11M
Revenue Growth
+17.50%
P/S Ratio
0.85
Revenue / Employee
437.87K
Employees
126
Market Cap
50.11M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202452.85M6.07M12.96%
Dec 31, 202346.79M-97.08M-67.48%
Dec 31, 2022143.87M64.78M81.91%
Dec 31, 202179.09M17.81M29.06%
Dec 31, 202061.28M30.67M100.19%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
NEUCA13.34B
Diagnostyka2.30B
Centrum Medyczne ENEL-MED820.59M
Synektik Spólka Akcyjna623.20M
Voxel568.83M
Selvita373.90M
Celon Pharma225.60M
Ryvu Therapeutics90.41M
Revenue Rankings